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Abstract
Background: This investigation offers insights into system-wide pathological processes induced in response to 
cigarette smoke exposure by determining its influences at the gene expression level.
Methods: We obtained genome-wide quantitative transcriptional profiles from 1,240 individuals from the San Antonio 
Family Heart Study, including 297 current smokers. Using lymphocyte samples, we identified 20,413 transcripts with 
significantly detectable expression levels, including both known and predicted genes. Correlation between smoking 
and gene expression levels was determined using a regression model that allows for residual genetic effects.
Results: With a conservative false-discovery rate of 5% we identified 323 unique genes (342 transcripts) whose 
expression levels were significantly correlated with smoking behavior. These genes showed significant over-
representation within a range of functional categories that correspond well with known smoking-related pathologies, 
including immune response, cell death, cancer, natural killer cell signaling and xenobiotic metabolism.
Conclusions: Our results indicate that not only individual genes but entire networks of gene interaction are influenced 
by cigarette smoking. This is the largest in vivo transcriptomic epidemiological study of smoking to date and reveals the 
significant and comprehensive influence of cigarette smoke, as an environmental variable, on the expression of genes. 
The central importance of this manuscript is to provide a summary of the relationships between gene expression and 
smoking in this exceptionally large cross-sectional data set.
Background
Tobacco use is responsible for more than 5 million deaths
per year [1] and is the leading preventable cause of pre-
mature death worldwide. Smoking is known to have a
major impact on human health, adversely affecting
almost every organ. Exposure to cigarette smoke
increases the risk of many diseases, including a wide
range of cancers (from lung to pancreatic cancer), cardio-
vascular diseases (including atherosclerosis and coronary
heart disease), a range of respiratory diseases (including
chronic obstructive pulmonary disease and pneumonia),
as well as various other adverse health effects such as
increased risk of cataracts, infection and poor wound
healing, and is generally detrimental to the overall health
of individuals who smoke [2-8].
Investigating the influence of cigarette smoke exposure
on health is a highly complex problem. The particulate
and vapor phase of cigarette smoke contains in excess of
4,000 compounds, including five known human carcino-
gens and many toxic agents [9,10]. These toxins enter the
bloodstream, via the pulmonary alveoli, and are distrib-
uted throughout the body. The widespread organ damage
in active smokers reflects the systemic distribution of
these compounds and the variety of cell types that are
exposed. Studies of the effects of cigarette smoking have
employed a variety of approaches to reduce the complex-
ity of the problem, such as studying animal models or
individual cell types in vitro that are exposed to 'standard-
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ized' measures of cigarette smoke, or to individual com-
ponents of the particulate or vapor phases. However, no
one model is able to capture the biological heterogeneity
of the effects.
This study utilized large-scale genome-wide expression
profiling as an alternative approach to determine the sys-
temic influence of cigarette smoke, as an environmental
exposure, on human physiology and health. Previous
studies of gene expression as influenced by smoking have
been seriously limited in size [11-21] with the largest of
the in vivo studies including only 42 smokers and 43 non-
smokers [15]. The small sample sizes and general lack of
power have resulted in little concordance between these
studies. Our hypothesis was that, given a sufficiently large
set of related individuals, a stable and interpretable pat-
tern of gene expression alterations attributable to ciga-
rette smoke exposure may be obtained. In addition, a
large and complex dataset allows for both the investiga-
tion of significant results at the individual gene level and
provides the ability to determine elaborate networks of
alteration. Studying these patterns of expression altera-
tion in response to cigarette smoke exposure may provide
the key to understanding the pathogenesis of many of the
adverse health effects attributable to smoking and the
interactions between them.
Methods
Ethics statement
All protocols were approved by the Institutional Review
Board of the University of Texas Health Science Center at
San Antonio. Participants gave informed consent and all
investigation were conducted according to the principles
expressed in the Declaration of Helsinki
Study population
This investigation was conducted as part of the SAFHS,
initiated in 1992 to investigate the genetics of cardiovas-
cular disease and its risk factors in Mexican Americans
[22]. Ascertainment occurred by way of adult probands
selected at random, without regard to presence or
absence of disease, from the Mexican American commu-
nity in San Antonio, Texas. To ensure large, multigenera-
tional pedigrees, probands had to have at least 6 age-
eligible offspring and/or siblings living in San Antonio.
All first, second, and third degree relatives of the proband
and of the proband's spouse, aged 16 years or above, were
eligible to participate in the study. More than 1,400 indi-
viduals from 42 extended families were recruited [22].
Reported family relationships were verified using the
computer program PREST [23], based on autosomal gen-
otype data, and corrections to the familial relationships
were applied where required. Existing blood samples and
phenotype data from the SAFHS were utilized in this
investigation.
Assessment of smoking status
Smoking status was assessed by structured interview con-
ducted during the first clinic visit between 1991 and 1995,
the same time point as the lymphocyte collection for the
expression profiling. Data collected included current
smoking status (smoker or non-smoker) as well as an esti-
mate of cigarettes smoked per day, all by self report. No
data were available on duration or former smoking status.
In addition, serum cotinine levels were measured using a
commercially available ELISA assay (BioQuant, San
Diego, California). Serum for the cotinine assay was
obtained during the first clinic visit but was only available
for 981 of the 1,240 individuals with expression profiles.
Expression profiling
The expression profiling methodology is described, in
detail, in Göring et al. (2007) [24]. In brief, frozen lym-
phocyte samples were available from 1,240 individuals,
collected during their first clinic visit between 1991 and
1995, after an overnight fast, in EDTA tubes. Lympho-
cytes were isolated from a 10 ml sample using Histopaque
(Sigma Chemical Co., St. Louis, MO), following the sug-
gested protocol of the manufacturer, washed, and stored
in a freeze media in liquid nitrogen.
Total RNA was isolated using a modified procedure of
the QIAGEN RNeasy® 96 protocol for isolation of total
RNA from animal cells using spin technology (QIAGEN
Inc., Valencia, CA), and a total of 500 ng total RNA dried
down and stored at -20°C. Anti-sense RNA (aRNA) was
synthesized, amplified and purified using the Ambion
MessageAmp II Amplification Kit (Ambion, Austin, TX)
following the Illumina Sentrix Array Matrix 96-well
expression protocol (Illumina Inc., San Diego, CA). Syn-
thesized cDNA samples were purified using QIAGEN's
QIAquick 96 PCR purification supplementary protocol
for spin technology (QIAGEN document QQ01.doc,
October 2001). Biotin-16-UTP (Roche, Germany) labeled
aRNA was synthesized using Ambion's proprietary
MEGAscript® in vitro transcription (IVT) technology and
T7 RNA Polymerase. Purification of aRNA samples was
performed using QIAGEN's RNeasy® 96 protocol for RNA
cleanup using spin technology, and a total of 1.5 μg aRNA
was dried and stored at -20°C prior to sample hybridiza-
tion.
Hybridization of aRNA to Illumina®  Sentrix®  Human
Whole Genome (WG-6) Series I BeadChips and subse-
quent washing, blocking and detecting were performed
using Illumina's BeadChip 6 × 2 protocol, as described in
Göring et al. [24]. Samples were scanned on the Illumina®
BeadArray™ 500GX Reader using Illumina®  BeadScan
image data acquisition software (version 2.3.0.13). Illu-
mina® BeadStudio software (version 1.5.0.34) was used for
preliminary data analysis, with a standard background
normalization, to generate an output file for statisticalCharlesworth  et al. BMC Medical Genomics 2010, 3:29
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analysis. In total we interrogated 47,289 unique tran-
scripts: 22,151 probes (47%) are targeted at Reference
Sequence (RefSeq) transcripts, and the remaining 25,128
probes (53%) correspond to other, generally less well
characterized transcripts (including predicted genes)
[24].
Identification of expressed transcripts
In order to identify transcripts that exhibited sufficient
quantitative expression in lymphocytes, the distribution
of expression values for a given transcript was compared
to the distribution of the expression values of the controls
that are imbedded in each chip. For each transcript, we
performed a χ2 "tail" test of whether there was a signifi-
cant excess of samples with values above the 95th percen-
tile of the control null distribution. This test was used
because it allows detection of even those transcripts that
are clearly present above baseline levels in only a subset
of individuals, while not being detectable above baseline
levels in most individuals. Using a false discovery rate of
0.05, we identified 20,413 transcripts that exhibited sig-
nificant expression by this criterion.
Standardization of expression values
To minimize the influence of overall signal levels, which
may reflect RNA quantity and quality rather than a true
biological difference between individuals, abundance val-
ues of all 20,413 retained transcripts were first standard-
ized by z-scoring within individuals (using decile
percentage bins of transcripts, grouped by average log-
transformed raw signals across individuals), followed by
linear regression against individual-specific average log-
transformed raw signal and its squared value. Lastly, for
each transcript, we directly normalized these residual
expression scores by employing an inverse Gaussian
transformation across individuals, to ensure that the
assumptions underlying variance components-based
analyses were not violated. This conservative procedure
results in normalized expression phenotypes that are
comparable between individuals and across transcripts.
Statistical Analyses
All statistical analyses on related individuals were per-
formed using variance components-based methodology
and software package SOLAR 4.1 [25]. To ensure that the
assumption of a multivariate normal phenotypic distribu-
tion was not violated, we subjected all phenotypes to an
exact inverse normalization procedure prior to analysis.
We tested for association between smoking and gene
expression levels using a regression model that allows for
residual genetic effects, as implemented in SOLAR. In
this approach, smoking was treated as a covariate for a
given transcript's expression level. A likelihood ratio sta-
tistic was used to formally test the hypothesis that smok-
ing was correlated with gene expression levels. This test
was performed conditionally upon other covariate effects
including those of sex, age, and their interactions. A false
discovery rate approach [26] was utilized to deal with the
major issue of multiple testing. We employed a rigorous
FDR of 0.05 for all analyses.
We used combined discrete-continuous bivariate mod-
eling analysis [27] to determine the environmental and
genetic correlations between smoking (as a discrete trait)
and expression of any given transcript (as a quantitative
trait). Formal likelihood-based tests were used to test the
difference of the genetic (ρg) and environmental correla-
tion (ρe) from zero.
Pathway and Networking Analysis
The 342 transcripts meeting the FDR of 0.05 criteria were
analyzed using Ingenuity Pathways Analysis version 6.3
(Ingenuity®  Systems, http://www.ingenuity.com). There
were 322 transcripts that mapped to known genes,
including two cases where three significant transcripts
corresponded to one gene (GNLY and PID1) and fifteen
cases where there were two significant transcripts within
a gene (BCN2, C9ORF142, CDH23, CLEC10A, FLJ16686,
LGR6, LMNA, LYPD2, MMP25, NCF4, SH2D3C, SNTB2,
SSBP3, TCF7L2, TRA@ and ZAK). In total there were 303
unique smoking correlated genes identified by IPA from
the list of 342 significant transcripts. There were 20 tran-
scripts that were unidentified and not included in the
analyses, predominantly because their identifier had been
retired or corresponded to a pseudogene (entrez gene IDs
28804, 80022, 255519) or hypothetical protein not yet
described in the literature. All 323 unique identifiers (303
known and 20 unknown) are shown in Additional File 1.
The right-tailed Fisher's exact test was used to calculate
a p-value determining the probability that each biological
function and/or disease assigned to that dataset was due
to chance alone. This p-value is calculated by comparing
the number of user-imported genes in a given function or
pathway relative to the total number of occurrences of
these genes in all functional/pathway annotations stored
in the knowledge base for the reference set. We used the
entire set of 20,413 transcripts that were significantly
detected in lymphocytes in our study [24] as the reference
set for this investigation.
Our genes of interest were overlaid onto a global
molecular network developed from literature reported
connectivity recorded in the Ingenuity Pathways Knowl-
edge Base, allowing the generation of gene networks;
graphical representation of the molecular relationships
between genes/gene products. All interactions between
genes and other molecules in these networks are sup-
ported by peer reviewed publication.Charlesworth  et al. BMC Medical Genomics 2010, 3:29
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Accession Number
Raw expression values (of all transcripts on the microar-
ray) and normalized expression values (of all 19,648 ana-
lyzed autosomal transcripts), along with information on
sex and age are available under accession number E-
TABM-305 on the ArrayExpress website http://
www.ebi.ac.uk/arrayexpress/.
Results
Study Summary
For this study, transcriptional profiles were obtained
from 1,240 Mexican American individuals from the San
Antonio Family Heart Study (SAFHS). This dataset con-
tained 1,154 individuals from 46 pedigrees and an addi-
tional 86 singletons. There were 734 females and 506
males in the sample, with a mean age of 39.3 years (SD =
16.7 years). Ages ranged between 16 and 94 years. For
each sample, 47,289 transcripts were interrogated using
the Sentrix Human-6 expression BeadChip supplied by
Illumina (San Diego, CA). We were able to significantly
detect 20,413 expressed transcripts in lymphocytes,
62.5% of these corresponding to known genes [24].
The prevalence of smoking in the dataset was 24%, with
297 current smokers. Using the genome-wide transcrip-
tional profile dataset, we tested for correlations of gene
expression in lymphocytes with a discrete measure of
current smoking behavior, assessed by questionnaire.
With a conservative false-discovery rate of 5%, corre-
sponding to an observed nominal p-value of < 0.001, we
identified 342 transcripts whose expression levels were
significantly correlated with smoking, 110 (32.2%) with
positive correlations and 232 (67.8%) negatively corre-
lated. These 342 transcripts correspond to 323 unique
genes. Details of this set of genes and the correlation of
expression with smoking are provided in Additional File
1. Increasing the FDR to 10% increased the number of
significant transcripts to 474, corresponding to an
observed nominal p-value of < 0.0028.
Validation of the phenotype
A quantitative measure of average cigarettes per day was
available in this study, but was deemed less-reliable than
the discrete trait, owing to bias introduced by self-report
[28]. However, analyses using the quantitative measure
did validate the set of smoking-correlated transcripts
identified using the more conservative discrete trait, with
a tetrachoric correlation of 0.905 ± 0.012 between tran-
scripts significantly correlated with each measure at a 5%
FDR.
In addition, plasma cotinine levels were available for a
subset (79.1%) of the 1,240 studied individuals. Cotinine
is a nicotine metabolite that is often used as a quantitative
measure of cigarette smoking; however cotinine levels are
subject to both genetic and environmental variation [29].
Using a plasma cotinine level of ≥20 for smoking and
≥300 for heavy smoking we only identified 17 individuals
whose self-reported smoking status was clearly misclassi-
fied. The tetrachoric correlation between plasma cotinine
levels and self-reported smoking status was extremely
high (0.979 ± 0.007).
Functional Annotation Analysis
In order to identify specific pathways and functional
assignments involved in the response to smoking, we per-
formed a series of formal pathway analyses. The 342 tran-
scripts meeting the FDR of 0.05 criteria were analyzed
using Ingenuity Pathways Analysis (IPA) version 6.3
(Ingenuity® Systems, http://www.ingenuity.com). A total
of 214 of the smoking-correlated genes included informa-
tion on functions and/or canonical pathways from the
published literature, which was used to identify overrep-
resentation of smoking correlated genes within known
categories of functional assignments (such as immune
response), and to develop hypotheses of gene action in
the context of wider biological relationships. The most
significant functional assignments included cell cytotox-
icity (p = 3.7 × 10-10), immune response (p = 2.2 × 10-7),
and tumorigenesis (p = 1.2 × 10-6). The most significant
functional assignments are shown in Table 1, along with
the p-value for the significance of each assignment and
the total number of smoking correlated genes within each
category. These are documented in more detail in Addi-
tional File 1, which includes the functional and canonical
pathway assignments for each individual transcript
within the dataset.
There were several highly significant functional catego-
ries involved in various aspects of cell death, including 17
genes involved in cell cytotoxicity (CD38,  CD300A,
FASLG,  FCGR3A,  FCGR3B,  GZMA,  GZMB,  KLRB1,
KLRD1,  KLRF1,  KLRK1,  PRF1,  PTGDR,  PTPN6,
SLAMF7, SPN, TNFRSF8; p = 3.7 × 10-10) and 11 in cell
lysis (ABCB1, CX3CR1, FASLG, FCGR3A, GNLY, GZMA,
GZMB, KLRB1, KLRD1, KLRK1, PRF1; p = 1.2 × 10-7)
that were all significantly negatively correlated with
smoking. In total there were 66 significant transcripts for
genes involved in various aspects of cell death (p = 1.1 ×
10-6), 47 negatively correlated and 19 positively correlated
with smoking.
There were 38 smoking-correlated genes involved in
immune response (p = 2.2 × 10-7), including 30 negatively
correlated with smoking (ADA,  C3,  CD38,  CD247,
CD300A, CST7, CTSC, CTSL1, CTSW, CX3CR1, FASLG,
FCGR3A,  FCGR3B,  GFI1,  GNLY,  GZMA,  GZMB,
IL18RAP,  IL2RB,  ITGAX,  KLRD1,  KLRF1,  KLRK1,
PIK3CG, PRF1, SPN, SPON2, TGFBR3, TNFRSF14 and
TRG@) and eight positively correlated genes (CLEC5A,
EBI2,  IGHE,  MGST1,  NCF4,  RNASE2,  SLAMF1  and
TPSAB1).Charlesworth  et al. BMC Medical Genomics 2010, 3:29
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In addition, in the cell proliferation category there were
27 smoking-correlated genes related to lymphocyte pro-
liferation, all but three of which were negatively corre-
lated (p = 5.2 × 10-7). Twenty-one inflammatory response
associated genes were significantly correlated with smok-
ing (p = 3.4 × 10-4), including fourteen that were nega-
tively correlated (ADA,  ADRB2,  C3,  CD38,  CHST2,
FASLG,  GLNY,  GZMA,  IL18RAP,  KLRG1,  PIK3CG,
PTGDR, PTPN6, SPON2 and TNFRSF14) and seven that
were positively correlated with smoking (CLEC5A, IGHE,
PLA2G7, RNASE2, S100A8, S100A12 and SERPINF1).
There was evidence of overrepresentation of cancer
related functional assignments, including 72 smoking-
correlated genes that were associated with tumorigenesis
(p = 1.2 × 10-6), 23 of which were positively correlated
with smoking and 49 negatively correlated genes. There
were also 64 genes associated with cancer (p = 4.9 × 10-6),
21 positively correlated with smoking (ACOX2,  AQP3,
CANX,  CLEC10A,  CYP1B1,  EBI2,  EPB41L3,  GPR177,
IGL@,  IL13RA1,  LDHA,  MGST1,  MMP25,  MTHFD2,
NRG1, PAICS, S100A8, SERPINF1, TFDP1, UGCG and
VCAN) and 43 negatively correlated genes (ABCB1,
ADA,  ADRB2,  AKR1C3,  ARIH2,  AXIN1,  C3,
CACNA2D2,  CD247,  CDKN1C,  CST7,  CTSC,  CTSL1,
EBF4,  FASLG,  FCGR3A,  GZMA,  HMOX1,  IL2RB,
KLRK1,  MT2A,  NCAM1,  ND3,  NEURL,  PALLD,
PGLYRP2,  PIK3CG,  PODN,  PPP2R2B,  PRF1,  PRSS23,
PTGDS, PTPN6, RASSF1, RHOC, RRAS, SLC1A7, SSBP3,
TGFBR3, TRA@, TRG@, TTC38 and UBE2C).
In relation to respiratory-relevant pathologies, there
were three genes associated with lung related cardiovas-
cular disorder that were all negatively correlated with
smoking (FASLG, HMOX1, PRF1; p = 1.4 × 10-4) and nine
genes involved in asthma (p = 5.9 × 10-4) including six
negatively correlated with smoking (ADRB2,  CX3CR1,
GZMB, HMOX1, PTGDR and TNFRSF8) and three posi-
tively correlated (IGHE, NRG1 and PLA2G7).
There was also some over-representation of free-radical
related functional assignments, including two genes
involved in mitochondrial perturbation (GZMB  and
PRF1; p = 2.7 × 10-4) and eight genes associated with free
radical scavenging (p = 3.1 × 10-3); seven negatively corre-
lated (FASLG, GZMA, GZMB, HMOX1, PIK3CG, PRF1,
RRAS) and one (IGHE) positively correlated with ciga-
rette smoking.
There were five significant canonical pathway catego-
ries of smoking correlated genes that also relate well to
known smoking pathologies, shown in Table 2. The most
Table 1: The most highly significant functional assignments for the set of smoking correlated genes
Function Annotation P-value Number of genes
Cell cytotoxicity 3.7 × 10-10 17
Proliferation of cells 2.1 × 10-9 65
Activation of cells 1.7 × 10-8 31
Cell movement 2.9 × 10-8 35
Lysis of cells 1.2 × 10-7 11
Immune response 2.2 × 10-7 38
Mobilization of calcium 4.0 × 10-7 19
Adhesion of cells 7.8 × 10-7 29
Cell death 1.1 × 10-6 66
Tumorigenesis 1.2 × 10-6 72
Binding of cells 2.9 × 10-6 21
Viral elimination 4.3 × 10-6 3
Cancer 4.9 × 10-6 64
Inflammatory disorder 5.3 × 10-6 44
Cell growth 5.6 × 10-6 50
Cardiovascular disorder of lung 1.4 × 10-4 3
Perturbation of mitochondria 2.7 × 10-4 2
Inflammatory response 3.4 × 10-4 18
Asthma 2.5 × 10-3 9
Free radical scavenging 3.1 × 10-3 8Charlesworth  et al. BMC Medical Genomics 2010, 3:29
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significant of these canonical pathways assignments was
for eleven genes involved in the natural killer cell signal-
ing pathway, all of which were negatively correlated with
smoking (CD247, CD300A, FCGR3A, FCGR3B, KLRB1,
KLRD1, KLRK1, PIK3CG, PTPN6, RRAS and SH2D1B; p
= 7.9 × 10-7).
There were ten genes involved in the xenobiotic metab-
olism signaling pathway in our dataset (p = 5.9 × 10-3),
eight negatively correlated (ABCB1,  CHST2,  CHST12,
HMOX1, PIK3CG, PPP2R2B, PPP2R5A and RRAS) and
t w o  t h a t  w e r e  p o s i t i v e l y  c o r r e l a t e d  w i t h  s m o k i n g
(CYP1B1 and MGST1). There were also four smoking-
correlated genes in the related metabolism of xenobiotics
by cytochrome P450 canonical pathway (p = 9.6 × 10-3),
including three positively correlated (CSGALNACT1,
CYP1B1 and MGST1) and one negatively correlated with
smoking (AKR1C3). Cigarette smoke is a significant
source of xenobiotics (chemicals foreign to the biological
system) and these potentially damaging compounds are
detoxified through such pathways.
Network Analysis
There were 243 smoking-correlated genes with known
connectivity information from published literature stored
in the Ingenuity Knowledge Base. We used this published
interaction information to determine whether our smok-
ing-correlated expression signatures are tightly con-
nected at the molecular level. This analysis is therefore
restricted to interactions derived from the published lit-
erature and does not identify novel interactions between
these genes. Network analysis was used to determine
whether our smoking-correlated expression signatures
are tightly connected at the molecular level, based only
on these known interactions, by generating graphical rep-
resentations of the interactions between genes and/or
gene products in our dataset. Network analysis was used
to connect 49 of the smoking correlated genes into a sin-
gle network of gene/gene product interaction (Figure 1).
This network includes a clear sub-network of 28 genes
known to be involved in immune and inflammatory
response (outlined in orange). Given their relevance to
cigarette smoke exposure, we included the external toxi-
cants nicotine and reactive oxygen species in the net-
work.
Genetic and Environmental Correlations of Expression with 
Smoking Behavior
Observed correlations between smoking behavior and a
given gene's expression level may be due to the causal
environmental effect of smoking on expression, the
shared genetic determinants that jointly influence tran-
scription level and the propensity to smoke, or a combi-
nation of these two influences. In order to assess the
relative importance of environmental versus genetic
sources of phenotypic covariation between expression
levels and smoking status, we performed bivariate quanti-
tative genetic analysis to decompose the observed pheno-
typic correlation of the 50 most significantly correlated
transcripts. Because of our large pedigree-based study
design, it is possible to directly estimate both the genetic
and environmental correlations between expression lev-
els and smoking status. Our results, documented in Addi-
tional File 2, clearly indicate that for all but one of the
transcripts tested (98%) we saw no evidence for genetic
correlation between smoking behavior and expression
levels as would be expected if the observed correlation
was the result of a genetic predisposition to smoking
behavior. Given the strength of the estimated environ-
mental component of covariation between smoking
behavior and expression levels, our observed correlations
most likely reflect the causal influence of smoking on
transcription levels, which suggests that smoking is act-
ing as a direct environmental mediator of transcription.
Discussion
This study is the largest investigation of gene expression
alterations in response to cigarette smoke exposure in
human subjects in vivo to date. The results clearly reveal
the broad influence of smoking, as an environmental
influence, on the lymphocyte transcriptome. The results
include a wide-ranging negative influence on the immune
system, and strong involvement in a range of other rele-
vant functional categories including cancer, cell death
and xenobiotic metabolism. It is likely that this observed
Table 2: The most highly significant canonical pathway assignments for the set of smoking-correlated genes
Canonical pathway P-value Number of genes
Natural killer cell signaling 7.9 × 10-7 11
CTLA4 Signaling in cytotoxic T 
lymphocytes
1.2 × 10-4 8
SAPK/JNK signaling 5.7 × 10-3 6
Xenobiotic metabolism signaling 5.9 × 10-3 10
Metabolism of xenobiotics by cytochrome 
P450
9.6 × 10-3 4Charlesworth  et al. BMC Medical Genomics 2010, 3:29
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effect of smoking on transcription has larger implications
for human disease risk, especially in relation to the
increased risk of a wide variety of cancers throughout the
body as a result of cigarette smoke exposure.
Peripheral lymphocytes appear to be an excellent surro-
gate tissue for investigating the effect of smoking on
health by transcriptomic epidemiology. Not only are they
one of the most readily and easily available tissues for
gene expression analysis, they have also been shown to be
a good surrogate for other tissue types in the case of envi-
ronmental exposures, such as cigarette smoke, polyaro-
matic hydrocarbons and radiation [30-32]. The biological
value of the lymphocyte as a surrogate for another more
directly involved tissue (e.g., lung tissue) does not require
that similar expression patterns be expressed between
lymphocytes and the more focal tissue. It merely requires
that, for a given gene, there is a phenotypic correlation
between expression levels in the two tissues, which is
much less restrictive than the requirements of similar
a b s o l u t e  p a t t e r n s  o f  e x p r e s s i o n .  A b s o l u t e  l e v e l s  a r e
immaterial to our central hypothesis. It is highly likely
that the regulatory machinery across tissue types is
Figure 1 A gene/gene product interaction network of smoking correlated genes. Networks of gene/gene product interaction were generated 
using IPA (Ingenuity® Systems, www.ingenuity.com). Genes or gene products are represented as nodes, and the biological relationship between two 
nodes is represented as an edge (line). All edges are supported by at least one published reference. Solid edges represent a direct relationship and 
dashed edges represent an indirect relationship. Node color represents the correlation of expression level with smoking, and the color intensity indi-
cates the degree of correlation (red represents positive correlation while green represents negative correlation). The shape of each node represents 
the functional class of the gene product, as shown in the key. Yellow nodes indicate exogenous toxicants manually added to the network. Genes 
known to be involved in immune/inflammatory response are highlighted in orange.Charlesworth  et al. BMC Medical Genomics 2010, 3:29
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altered by mechanisms of attenuation or amplification
which would lead to dramatically different absolute levels
but still generate correlations between tissue types. If the
attenuation/amplification mechanism has a linear com-
ponent, then correlations will obligately result. Therefore,
any regulatory feature that is shared across tissues will
generate a correlation between tissues. Thus, a gene may
be very highly expressed in one tissue and lowly
expressed in a different tissue and still exhibit correlation
between tissues. Such correlations are beginning to be
demonstrated across a number of tissues [26].
Lymphocytes may be directly relevant for assessing the
damaging effects of cigarette smoke. Thousands of ciga-
rette smoke constituents are rapidly absorbed into the
bloodstream, through the pulmonary alveoli, where they
rapidly achieve systemic distribution. Oxidative damage
and polycyclic hydrocarbon adducts have been readily
detected, not only the respiratory epithelium and other
first sites of exposure in cigarette smokers, but also in the
blood and peripheral lymphocytes [33,34]. In addition, of
the 47,289 transcripts interrogated in our study, we were
able to significantly detect 20,413 expressed transcripts in
lymphocytes, including both known and predicted genes
[24]. This is an impressive level of diversity for any tissue,
and allows the flexibility to identify signatures of gene
expression correlated with a range of traits. Finally, since
smoking is a major risk factor for a wide variety of can-
cers and diseases in a range of tissue types, it is important
to understand its influence at the gene level outside of a
selected cancer model.
All of the most significant functional groupings of
smoking correlated genes identified in this study are
directly relevant to well known smoking related disease
processes. Cell death and proliferation, immune
response, cancer, inflammatory disease and xenobiotic
metabolism are all relevant groupings for smoking corre-
lated genes, given known smoking related pathologies.
However, the extent of these relevant groupings and the
number of correlated genes whose expression is influ-
enced by smoke exposure within each group is striking.
Various aspects of depressed immune function have
been well documented in smokers [9,35-40]. We identi-
fied sets of smoking correlated genes corresponding to
immune system components that fit with this profile of
wide-spread immune alteration and suppression. For
example, all 17 genes associated with cell cytotoxicity
were negatively correlated with smoking; of the 29 genes
involved in immune response (Table 1), the expression
levels of 23 were negatively correlated with smoking; and
of the sixteen genes involved in inflammatory response,
twelve were negatively correlated with smoking. All
eleven genes in the natural killer (NK) cell signaling path-
way (Table 2), involved in cytotoxicity and cytokine
secretion, were also negatively correlated with smoking.
This wide-ranging negative influence on the immune sys-
tem is one of the clearest pictures to emerge from our
transcriptional profiling of smoking and gene expression.
This comprehensive influence on immune related gene
expression may go a long way towards explaining the pro-
cesses behind the depressed immune system related
pathologies exhibited by smokers.
As mentioned above, the expression levels of eleven
genes in the natural killer (NK) cell signaling pathway
w e r e  n e g a t i v e l y  c o r r e l a t e d  w i t h  s m o k i n g  ( CD247,
CD300A,  FCGR3A,  FCGR3B, KLRB1, KLRD1,  KLRK1,
PIK3CG, PTPN6, RRAS and SH2D1B). NK cells are lym-
phocytes of the innate immune system involved in early
defense against foreign cells and stressed autologous cells,
and their cytotoxic activity is known to be decreased in
smokers [36]. In addition, NK cell tumor immune surveil-
lance was recently shown to be decreased in response to
s m o k e  e x p o s u r e  i n  a  m u r i n e  l u n g  m e t a s t a t i c  t u m o r
model [41]. Our findings corroborate this negative influ-
ence of cigarette smoke on NK cell activity, and reveal
some of the gene level alterations that may influence NK
cells in smokers.
Another striking finding of this study was the over-rep-
resentation of functional groupings relevant to cancer
and cancer relevant processes such as cell death, prolifer-
ation and signaling. Cigarette smoking is a recognized
risk factor for a wide variety of cancers, not only at the
sites of contact such as the lungs and esophagus, but also
throughout the body such as pancreatic, kidney, colon
and bladder cancer. Correlations between expression of
genes in lymphocytes and cigarette smoking in this study
provide insight into the cancer relevant biological pro-
c e s s e s  o c c u r r i n g  t h r o u g h o u t  t h e  b o d y  i n  r e s p o n s e  t o
smoke exposure, and hopefully serve to highlight the
complexity of these processes.
We constructed a complex network based on published
interaction between genes and/or gene products for 49 of
the transcripts that were significantly correlated with
smoking (Figure 1) including a clear sub-network of 28
genes known to be involved in immune and inflammatory
response (outlined in orange). A portion of this network
is also clustered around the exogenous toxicants nicotine
a n d  r e a c t i v e  o x y g e n  s pe c i e s,  wi t h  m o s t  o f  t h e s e  g e n e s
involved in xenobiotic metabolism and free radical scav-
enging (FASLG,  GZMA,  GZMB,  HMOX1,  IGHE,
PIK3CG, PRF1 and RRAS). The network displayed in Fig-
ure 1 clearly reveals the massive scale of influence that
cigarette smoke, as an environmental variable, exerts over
the lymphocyte transcriptome; however we are unable to
determine which genes are directly influenced by smoke
exposure, given that alteration of the expression level of
one gene can alter the transcription of other genes in
these networks. These interactions are made even more
complex by the diversity of cigarette smoke components,Charlesworth  et al. BMC Medical Genomics 2010, 3:29
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and the variability of this constitution, in that we cannot
identify which component(s) of cigarette smoke are
exerting the most influence over gene expression. In
addition, the network analysis is dependent on published
connectivity information and as such cannot fully reflect
the complexity of the interactions or reveal any novel
connectivity. The literature reported interaction direc-
tionality is also of limited use in interpreting the empiri-
cal data, since our results reflect the state of the whole
living organism. The observed correlations may reflect a
large number of mediating factors including complex
feedback loops that could easily be missed using classical
in vitro cell-based models of cause and effect. However,
this network does show that the genes whose expression
is altered in response to cigarette smoke are tightly con-
nected at the molecular level, and gives some indication
of the pathways through which cigarette smoke influ-
ences known smoking related pathologies such as inflam-
mation.
Although smoking has long-term adverse effects, cessa-
tion has some immediate, as well as long-term benefits,
which may be due to a reversal of these transcriptomic
alterations. Many of the negative health effects have been
shown to be reversed or at least improved soon after ces-
sation [4,41,42], for example elevation of NK activity
(which is suppressed in smokers) is detectable within one
month of smoking cessation [43]. This further supports
the implication that at least part of the NK cell activity
suppression is due to gene-level alterations in expression
induced by smoke exposure, which may be reversed as
the exposure is removed. However, a study comparing
transcriptional profiles of 34 smokers, 23 non-smokers
and 18 former smokers revealed that, while the majority
of smoke exposure related gene expression alterations
return to normal in former smokers, there were a set of
transcripts that appeared to retain altered expression pat-
terns two-years after smoking cessation [16]. Similarly,
Beane  et al. showed that 16% of the 175 differentially
expressed genes identified in airway epithelial cells
between smokers and non-smokers were irreversibly
altered in former smokers [12]. Therefore, while it
appears that the majority of gene expression alterations
attributable to smoke exposure may be reversible, there
may also be a subset of genes for which the expression
changes are permanent or at least altered in the long
term.
This study has some intrinsic limitations that should be
noted. The study was conducted in a population of Mexi-
can American individuals and it is difficult to determine
what proportion of the expression changes would be rep-
licated in other populations. While results obtained from
within a subset of the population may not necessarily be
relevant to all subsets of the population, in general it is
highly likely that the majority of genes whose expression
is altered in Mexican American individuals in response to
smoke exposure are the same genes susceptible to altera-
tion in other population groups. Transcriptional altera-
tions are likely more robust to population differences
than studies of individual genetic variants. However, a
subset of the genes identified in this study may only be
relevant to the Mexican American population. It is also
important to note that, while not likely, it is possible that
cigarette smoking is a surrogate for some other influence
that is initiating the transcriptional alterations in this
study.
Conclusions
The results of this investigation offer insights into ciga-
rette-smoke related pathological processes by determin-
ing its influences at the gene expression level. Never
before has such a clear link between smoking and tran-
scriptomics been revealed, and the scale at which expo-
sure to cigarette smoke appears to influence the
expression levels of our genes is sobering.
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